Antibacterial nasal compositions and related methods
AssigneeXlear, Inc.
InventorsAlonzo H. Jones, Nathan Jones
Life of this patent
Estimating the term…
Abstract
Methods for treatment of infections, such as nasal infections, sinus infections, ear infections, and/or lung infections, along with related compositions. In some implementations, a treatment method may comprise delivering a dose of the composition into a subject's nasal passage to treat the infection. The composition may comprise an antibiotic agent, such as ciprofloxacin. The composition may further comprise at least one non-hexose, sugar alcohol, such as xylitol. Preferably, the dose comprises a sub-clinical dose of the ciprofloxacin or other antibiotic agent.
Claims20
A method for treatment of an infection using a nasal composition, wherein the method comprises the steps of:
- identifying a subject having an infection, wherein the infection is at least one of a sinus infection, a nasal infection, and an ear infection;
- delivering a dose of the composition into the subject's nasal passage, wherein the composition comprises:
- at least one of ciprofloxacin and ciprofloxacin hydrochloride;
- and
- at least one of xylitol and xylose.
A method for treatment of an infection using a nasal composition, wherein the method comprises the steps of:
- identifying a subject having an infection;
- delivering a dose of the composition into the subject's nasal passage, wherein the composition comprises:
- an antibiotic agent;
- and
- at least one non-hexose, sugar alcohol in a concentration of between about 5 and about 20 weight percent, and wherein the dose comprises a sub-clinical dose of the antibiotic agent.
A method for treatment of an inner ear infection using a nasal composition, wherein the method comprises the steps of:
- identifying a subject having an inner ear infection;
- delivering a dose of the composition into the subject's nasal passage, wherein the composition comprises:
- ciprofloxacin in a concentration of between about 0.1 and about 0.5 weight percent;
- and
- at least one of xylitol and xylose in a concentration of between about 5 and about 20 weight percent, and wherein the dose comprises:
- ciprofloxacin in an amount between about 20 mg and about 75 mg.
Dependencies are inferred from the claim text.